Double negative alpha beta T cells in pediatric hemophagocytic syndromes
Hossny, E., El-Owaidy, R., Afifi, H., Ahmad, H. (2019). Double negative alpha beta T cells in pediatric hemophagocytic syndromes. EKB Journal Management System, 17(1), 13-19. doi: 10.21608/ejpa.2019.41533
Elham Hossny; Rasha El-Owaidy; Hanaa Afifi; Hadeer Ahmad. "Double negative alpha beta T cells in pediatric hemophagocytic syndromes". EKB Journal Management System, 17, 1, 2019, 13-19. doi: 10.21608/ejpa.2019.41533
Hossny, E., El-Owaidy, R., Afifi, H., Ahmad, H. (2019). 'Double negative alpha beta T cells in pediatric hemophagocytic syndromes', EKB Journal Management System, 17(1), pp. 13-19. doi: 10.21608/ejpa.2019.41533
Hossny, E., El-Owaidy, R., Afifi, H., Ahmad, H. Double negative alpha beta T cells in pediatric hemophagocytic syndromes. EKB Journal Management System, 2019; 17(1): 13-19. doi: 10.21608/ejpa.2019.41533

Double negative alpha beta T cells in pediatric hemophagocytic syndromes

The Egyptian Journal of Pediatric Allergy and Immunology
Article 3, Volume 17, Issue 1, April 2019, Page 13-19  XML PDF (260.22 K)
Document Type: Original Article
DOI: 10.21608/ejpa.2019.41533
View on SCiNiTO View on SCiNiTO
Authors
Elham Hossny1; Rasha El-Owaidyorcid 2; Hanaa Afifi3; Hadeer Ahmad4
1Pediatric allergy and immunology unit, Ain Shams University, Cairo, Egypt
2MD, PhD. Lecturer of Pediatrics and Pediatric Allergy and Immunology, Ain-Shams University, Egypt. Member, ESPAI, WAO, EAACI, ESID, ASID
3Clinical pathology department, faculty of medicine, ain sham university
4Ministry of health public hospitals, Cairo, Egypt
Abstract
Introduction: Autoimmune lymphoproliferative syndrome (ALPS) and
hemophagocytic lymphohistiocytosis (HLH) share clinical and laboratory
features including lymphadenopathy, splenomegaly, and pancytopenia. We
sought to measure αβ double negative T cells (αβ DNT) in a group of
patients with established diagnosis of HLH in relation to disease activity and
severity. Methods: We conducted a follow-up, controlled study that
comprised 25 patients with HLH and 25 healthy matched controls. Patients
were subjected to clinical evaluation and flowcytometric measurement of αβ
DNT Cells at presentation and 9 weeks after start of HLH induction
treatment. Results: In 17 (68%) patients, infection was the trigger of HLH
while the cause was malignancy in three (12%), and rheumatological
disorders in two patients (8%). At enrollment, 15 patients (60%) had αβ
DNT cells levels [median (IQR): 1.71 (1.25-2.12)] that were significantly
higher than the control values [median (IQR): 0.7 (0.4-0.8)] (p<0.001). The
αβ DNT counts of patients were also higher at enrollment as compared to
values at the end of week 9 [median (IQR): 0.76 (0.45-1.17)]; p=0.018.
Survivors (n=8) and non-survivors (n=17) had comparable levels of αβ DNT
cells at enrollment (p=0.861). αβ DNT cell count correlated positively with
ALT (p=0.019) and negatively with CD4/CD8 ratios (p=0.023).
Conclusion: Elevated αβ DNT cell counts might be related to the HLH
process and this implies that mild elevation can exist in HLH and are not
specific to ALPS. Wider scale studies with longer periods of follow up are
needed to validate the results and properly outline the correlation between
both medical conditions.
Keywords
Hemophagocytic lymphohistiocytosis; Double negative T cells; mortality; ALPS
Statistics
Article View: 159
PDF Download: 242